Michael Straßer

2.6k total citations
47 papers, 1.5k citations indexed

About

Michael Straßer is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, Michael Straßer has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 30 papers in Hepatology and 5 papers in Hematology. Recurrent topics in Michael Straßer's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (11 papers). Michael Straßer is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (11 papers). Michael Straßer collaborates with scholars based in Austria, Switzerland and Germany. Michael Straßer's co-authors include Christian Datz, Elmar Aigner, A Maieron, Rudolf Stauber, Heike Haufe, Harald Hofer, Péter Ferenci, Petra Steindl‐Munda, Günter Weiß and Albert Friedrich Stättermayer and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

Michael Straßer

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Straßer Austria	19	1.0k	807	189	180	153	47	1.5k
Albert Friedrich Stättermayer Austria	27	1.6k 1.6×	1.6k 2.0×	102 0.5×	369 2.0×	120 0.8×	94	2.3k
Jean‐Charles Duclos‐Vallée France	29	1.5k 1.4×	1.7k 2.1×	109 0.6×	76 0.4×	135 0.9×	116	2.5k
Rodolphe Sobesky France	14	925 0.9×	975 1.2×	96 0.5×	132 0.7×	78 0.5×	48	1.5k
Michiari Okuda Japan	15	1.2k 1.2×	1.2k 1.5×	48 0.3×	132 0.7×	125 0.8×	28	1.9k
Makoto Oketani Japan	24	1.1k 1.1×	1.2k 1.4×	188 1.0×	54 0.3×	70 0.5×	68	1.9k
Masaaki Korenaga Japan	24	1.6k 1.6×	1.5k 1.9×	71 0.4×	118 0.7×	73 0.5×	79	2.4k
Yoshio Tokumoto Japan	22	1.1k 1.1×	840 1.0×	243 1.3×	61 0.3×	61 0.4×	124	1.6k
Agustín Castiella Spain	17	574 0.6×	430 0.5×	31 0.2×	139 0.8×	84 0.5×	80	1.5k
Guido Ronchi Italy	23	2.1k 2.0×	2.1k 2.6×	43 0.2×	84 0.5×	62 0.4×	35	2.9k
Federica Botta Italy	20	1.6k 1.6×	1.5k 1.9×	70 0.4×	57 0.3×	31 0.2×	40	2.1k

Countries citing papers authored by Michael Straßer

Since Specialization

Citations

This map shows the geographic impact of Michael Straßer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Straßer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Straßer more than expected).

Fields of papers citing papers by Michael Straßer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Straßer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Straßer. The network helps show where Michael Straßer may publish in the future.

Co-authorship network of co-authors of Michael Straßer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Straßer. A scholar is included among the top collaborators of Michael Straßer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Straßer. Michael Straßer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Camilla Dalby, Lorenz Balcar, K. Bech, et al.. (2025). PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis. JHEP Reports. 8(1). 101649–101649.

Semmler, Georg, Lorenz Balcar, Hannes Oberkofler, et al.. (2021). PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. Journal of Personalized Medicine. 11(3). 165–165. 10 indexed citations

Balcar, Lorenz, Georg Semmler, Hannes Oberkofler, et al.. (2021). PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center. Digestive and Liver Disease. 54(1). 84–90. 4 indexed citations

Stechemesser, Lars, Sebastian K. Eder, Andrej Wagner, et al.. (2016). Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. Molecular Metabolism. 6(1). 38–47. 32 indexed citations

Stättermayer, Albert Friedrich, Stefan Traussnigg, Hans‐Peter Dienes, et al.. (2015). Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations. Journal of Hepatology. 63(1). 156–163. 73 indexed citations

Beinhardt, S., K Kozbial, A. Schmidt, et al.. (2015). P0871 : Real life experience with interferon/ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with hepatitis C virus. Journal of Hepatology. 62. S667–S667. 1 indexed citations

Melchardt, Thomas, Teresa Magnes, Lukas Weiß, et al.. (2014). Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. BMC Complementary and Alternative Medicine. 14(1). 115–115. 16 indexed citations

Scherzer, Thomas–Matthias, Albert Friedrich Stättermayer, Rudolf Stauber, et al.. (2013). Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients. Journal of Hepatology. 59(5). 964–971. 14 indexed citations

Stättermayer, Albert Friedrich, Robert Straßl, A Maieron, et al.. (2013). Polymorphisms of interferon-λ4andIL28B- effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 39(1). 104–111. 44 indexed citations

10.

Beinhardt, S., B.A. Payer, Christian Datz, et al.. (2013). A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection. Journal of Hepatology. 59(5). 972–977. 21 indexed citations

11.

Straßer, Michael, Elmar Aigner, Andreas Stadlmayr, et al.. (2013). Risk of Hepatitis C Virus Transmission from Patients to Healthcare Workers: A Prospective Observational Study. Infection Control and Hospital Epidemiology. 34(7). 759–761. 2 indexed citations

12.

Stadlmayr, Andreas, Elmar Aigner, Bernhard Steger, et al.. (2011). Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. Journal of Internal Medicine. 270(1). 41–49. 106 indexed citations

13.

Beinhardt, S., Judith H. Aberle, Michael Straßer, et al.. (2011). Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection. Gastroenterology. 142(1). 78–85.e2. 78 indexed citations

14.

Stättermayer, Albert Friedrich, Rudolf Stauber, Harald Hofer, et al.. (2010). Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 9(4). 344–350.e2. 144 indexed citations

15.

Giugliano, Silvia, Jörg Timm, Falko M. Heinemann, et al.. (2010). Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. Journal of Hepatology. 54(2). 201–208. 25 indexed citations

16.

Ferenci, Peter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2009). Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response. Gastroenterology. 138(2). 503–512.e1. 86 indexed citations

17.

Aigner, Elmar, Igor Theurl, Milan Theurl, et al.. (2008). Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. American Journal of Clinical Nutrition. 87(5). 1374–1383. 155 indexed citations

18.

Ferenci, Péter, H. Brünner, Hermann Laferl, et al.. (2008). A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology. 47(6). 1816–1823. 49 indexed citations

19.

Schmid, Daniela, R. Fretz, Christoph König, et al.. (2008). Foodborne outbreak of hepatitis A, November 2007–January 2008, Austria. European Journal of Clinical Microbiology & Infectious Diseases. 28(4). 385–391. 25 indexed citations

20.

Jessner, Wolfgang, Michael Straßer, Ivo Graziadei, Frieder Berr, & Wolfgang Vogel. (2006). Sustained remission of chronic hepatitis C after acute hepatitis B superinfection. Scandinavian Journal of Infectious Diseases. 38(9). 818–821. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact